Polygiene AB (publ.) Share Price Nasdaq Stockholm
Equities
SE0007692157
Specialty Chemicals
Sales 2024 * | 145M 13.53M 1.13B | Sales 2025 * | 161M 15.03M 1.25B | Capitalization | 327M 30.48M 2.54B |
---|---|---|---|---|---|
Net income 2024 * | 20M 1.87M 155M | Net income 2025 * | 17M 1.59M 132M | EV / Sales 2024 * | 1.93 x |
Net cash position 2024 * | 46M 4.29M 357M | Net cash position 2025 * | 57M 5.32M 443M | EV / Sales 2025 * | 1.67 x |
P/E ratio 2024 * |
16.3
x | P/E ratio 2025 * |
19.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.11% |
Managers | Title | Age | Since |
---|---|---|---|
Ulrika Bjork
CEO | Chief Executive Officer | 56 | 10/17/10 |
Niklas Blomstedt
DFI | Director of Finance/CFO | - | 15/22/15 |
Sue Bethel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 01/19/01 | |
Director/Board Member | 71 | 11/23/11 | |
Daniel Röme
CTO | Chief Tech/Sci/R&D Officer | 48 | 01/18/01 |
1st Jan change | Capi. | |
---|---|---|
+17.80% | 66.43B | |
+2.92% | 49.89B | |
+19.98% | 41.88B | |
+20.88% | 26.48B | |
+12.04% | 19.68B | |
+1.27% | 17B | |
-22.98% | 16.12B | |
+2.77% | 15.28B | |
-9.25% | 15.18B |